No gene acts alone: interacting variants and protein partnerships can worsen, mask or even rescue disease risk, demanding ...
The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.
New one-dose treatment edits a gene in the liver, disabling the ANGPTL3 protein and significantly lowers cholesterol.
Sometimes, in genetics, two wrongs do make a right. A research team has recently shown that two harmful genetic variants, ...
In a groundbreaking study published in the in Proceedings of the National Academy of Sciences (PNAS), scientists at Pacific ...
Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...
Researchers from the Bakkers group at the Hubrecht Institute have successfully repaired damaged mouse hearts using a protein ...
Artistic representation of heart regeneration: Hmga1 in green symbolically flows from the border zone of a zebrafish heart (top right) to the injured border zone of a mouse heart (left). Red ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback